For disciplined, long-term investors, the week ending October 30, 2026, was a classic example of market rotation and the valuation sensitivity of investors. While mega-cap technology shares stumbled under ongoing scrutiny of their capital spending outlays amidst mixed third-quarter earnings, smaller, fundamentally grounded businesses demonstrated noteworthy relative resilience.

The broader market finished mixed as the S&P 500 slipped roughly 0.56% and the tech-heavy Nasdaq-100 fell 1.97%. In contrast, the S&P SmallCap 600 index showed positive momentum, with small-cap equities advancing roughly 1.2% to 1.3% for the week, settling in at 1,706.25.

For October 2026, the S&P SmallCap 600 maintained a modest gain of around 1.1%. In contrast, the large-cap indexes turned negative as tech leadership faded. Year-to-date through late October, the S&P SmallCap 600 has advanced about 11.2%, with the S&P SmallCap 600 Value index climbing approximately 18.9%. Over the trailing twelve months, the S&P SmallCap 600 has logged a solid gain near 14.5%, supported by trailing P/E valuations hovering around 16.5 times earnings. The index's strict entry requirement for positive cumulative earnings continues to reward patient shareholders with higher-quality holdings than unvetted small-cap baskets.

Economic news in the week confirmed ongoing resilience alongside a whiff of monetary caution. The Federal Open Market Committee left the benchmark federal funds target range unchanged at 3.75% to 4.00%. Fed policymakers reiterated that current credit conditions are firm and future policy will remain strictly data-dependent. Third-quarter GDP indicators showed steady expansion driven by consumer spending and business fixed investment.

Sector performers leaned heavily toward defensive and cash-flow-rich segments. Healthcare led all sectors with a 3.12% weekly advance, followed by Basic Materials and Industrials, while Technology slumped 2.03%. Results for individual stocks were wildly varying. In large-cap technology, ServiceNow plunged 33.9% after missing projections, and Intel slid 24.4% following cautious forward guidance. On the other side, select mid- and small-cap healthcare names saw dramatic surges; Replimune Group soared 53.7% and Surgery Partners jumped 47.4%.

As we enter November, market participants find themselves managing two distinct horizons. In the near term, investors are scrutinizing corporate earnings guidance to see whether high P/Es remain justifiable in an environment where interest rates stay near 4%. For the long term, investors are asking whether the decade-long dominance of mega-cap growth is giving way to a sustained broadening of market participation. Identifiable trends suggest that capital is increasingly prioritizing cash-flow sustainability, low financial leverage, and realistic valuations over unproven future growth projections.

Prudent investors know that broad-market headlines often obscure genuine opportunities, making regular, disciplined additions to high-quality, profitable small businesses an enduring strategy.

In the SmallCap Informer

Homebuilders entered late October trading at deeply depressed, single-digit forward price-to-earnings multiples against a drumbeat of bleak housing headlines, including the NAHB/Wells Fargo Housing Market Index sinking to 29 (its weakest print since 2012) and record price concessions. However, the rotation of stocks away from mega-cap technology and into interest-rate-sensitive cyclicals supported the advance of several companies in the SmallCap Informer coverage list involved in construction and housing markets. Since the November 2026 issue of SCI was published on October 16, 2026, several companies have seen big price gains:

• Cavco Industries (CVCO) +17.2%
• Installed Building Products (IBP) +13.3%
• Simpson Manufacturing (SSD) +12.3%
• Eagle Materials (EXP) +12.0%

There is still time to subscribe to SCI before our December 2026 issue is published. Take advantage of this offer for new subscribers. Subscribe today and get your portfolio into gear to benefit from the small-cap market's current resilience.

Stay the course!

— DOUG GERLACH, EDITOR-IN-CHIEF

Get great small company stock ideas in each issue of the SmallCap Informer stock newsletter. Subscribe to the SmallCap Informer and get monthly small company stock recommendations and updated buy/sell prices for each of the ~40 high-quality small company stocks currently covered in the newsletter.